BODMER MARK (CSO, President of R&D) sold 15.8% of their position (3.13K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $29.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/9/2023ACC: 0001694665-23-000136
Officer· CSO, President of R&D
Since Jan 2019
-3.13K
Net shares
Net seller
$29.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.63K acquired · 9.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.63K
Price / share
—
Trade value
—
% of position
50.5%
8/7/2023
13.13K→19.75K
Common Stock
Direct
Shares
−3.13K
Price / share
$9.51
Trade value
$29.75K
% of position
15.8%
8/8/2023
19.75K→16.62K
Total
Net shares
+3.50K
Net value
-$29.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2023 | M · Option Exercise | +6.63K | — | — | 50.5% | 13.13K | 19.75K |
| Common Stock Direct | 8/8/2023 | S · Sale | −3.13K | $9.51 | $29.75K | 15.8% | 19.75K | 16.62K |
| Total | +3.50K | -$29.75K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.63K shares
Shares
−6.63K
Strike price
Held after
13.25K
Exercisable
—
8/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.63K shares | 8/7/2023 | M · Option Exercise | −6.63K | — | 13.25K |